What are the major opportunities in the Thyroid Eye Disease (TED) market? What are the strategies for the Thyroid Eye Disease (TED) market?

For detailed insights on the major opportunities and strategies in the Thyroid Eye Disease (TED) market, Read More

How does the Thyroid Eye Disease (TED) market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Thyroid Eye Disease (TED) market growth and SWOT analysis of the Thyroid Eye Disease (TED) industry, Read More

For detailed insights on the mergers and acquisitions in the Thyroid Eye Disease (TED) industry,

What are the key dynamics influencing the Thyroid Eye Disease (TED) market growth? SWOT analysis of the Thyroid Eye Disease (TED) market. Read More

Global Thyroid Eye Disease (TED) Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Thyroid Eye Disease (TED) Global Market Report 2025

Name: Thyroid Eye Disease (TED) Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment Type (Medical, Surgical, Combination Of Medical And Surgical), By Disease Severity (Mild, Moderate, Severe), By Drug Type (Biologics, Small Molecules, Others Drug Type), By Route Of Administration (Oral, Intravenous, Subcutaneous), By End User (Hospitals, Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Thyroid Eye Disease (TED) Market Overview

• Thyroid Eye Disease (TED) market size has reached to $2.15 billion in 2024

• Expected to grow to $2.94 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%

• Growth Driver: Thyroid Disorders And Their Influence On The Market Dynamics

• Market Trend: Amgen's TEPEZZA (Teprotumumab)A Breakthrough In Thyroid Eye Disease Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Thyroid Eye Disease (TED) Market?

Thyroid eye disease (TED), also known as Graves' Orbitopathy, is an autoimmune condition characterized by inflammation and swelling of the tissues around the eyes, often associated with thyroid disorders. TED can cause symptoms such as bulging eyes, double vision, and eye pain.

The main treatment types of thyroid eye disease (TED) are medical, surgical, and a combination of medical and surgical approaches. Medical treatment of thyroid eye disease (TED) typically involves the use of corticosteroids, immunosuppressive drugs, and biologic therapies to reduce inflammation, control symptoms, and prevent disease progression. It is tailored based on the disease severity, which can be classified into mild, moderate, and severe stages. Drugs used for treatment fall into different categories, including biologics, small molecules, and others. It is available in various routes of administration options, including oral, intravenous, and subcutaneous delivery methods and are used by several end users such as hospitals, clinics, and others.

Thyroid Eye Disease (TED) Market Size and growth rate 2025 to 2029: Graph

What Is The Thyroid Eye Disease (TED) Market Size 2025 And Growth Rate?

The thyroid eye disease (TED) market size has grown strongly in recent years. It will grow from $2.15 billion in 2024 to $2.29 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising thyroid disorders, growing focus on patient-centered care, increasing demand for cosmetic procedures, increasing prevalence of the disease, and increasing treatment options for TED.

What Is The Thyroid Eye Disease (TED) Market Growth Forecast?

The thyroid eye disease (TED) market size is expected to see strong growth in the next few years. It will grow to $2.94 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the increasing prevalence of Graves' disease, increasing funding in various industries, increasing healthcare expenditure, increasing use of thyroid hormone replacement therapy, and rising incidence of thyroid disease. Major trends in the forecast period include technological advancements, expanding R&D activities, development of novel drugs, advancements in treatment options, and new surgical techniques.

The forecast of 6.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. medical supply chains by increasing costs for teprotumumab infusions and orbital radiation therapy equipment imported from Ireland and the Netherlands, potentially compromising vision-saving interventions and raising ophthalmology clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Thyroid Eye Disease (TED) Market Segmented?

1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical

2) By Disease Severity: Mild, Moderate, Severe

3) By Drug Type: Biologics, Small Molecules, Others Drug Type

4) By Route Of Administration: Oral, Intravenous, Subcutaneous

5) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments

2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery

3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches

What Is Driving The Thyroid Eye Disease (TED) Market? Thyroid Disorders And Their Influence On The Market Dynamics

Rising thyroid disorders are expected to propel the growth of the thyroid eye disease (TED) market going forward. Thyroid disorders are medical conditions that affect the function of the thyroid gland, leading to imbalances in hormone production and resulting in conditions such as hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. Rising thyroid disorders are driven by factors such as increased iodine intake, autoimmune conditions, genetic predisposition, and greater awareness leading to improved diagnostic rates. Thyroid Eye Disease (TED) contributes to the rise in thyroid disorder cases, as it is a common and serious complication of Graves' disease, increasing the overall burden and awareness of thyroid-related conditions. For instance, in May 2024, according to the Canadian Cancer Society, a Canada-based non-profit, community-based organization, in 2024, an estimated 6,600 new cases of thyroid cancer are expected to be diagnosed in Canada, with approximately 280 fatalities projected. Therefore, rising thyroid disorders are driving the growth of the thyroid eye disease (TED) industry.

Who Are The Major Players In The Global Thyroid Eye Disease (TED) Market?

Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

What Are The Key Trends Of The Global Thyroid Eye Disease (TED) Market? Amgen's TEPEZZA (Teprotumumab)A Breakthrough In Thyroid Eye Disease Treatment

Major companies operating in the thyroid eye disease (TED) market are focusing on innovative products, such as monoclonal antibody therapies, to develop more effective, targeted treatments that reduce inflammation, improve proptosis, and enhance overall patient outcomes. Monoclonal antibody therapies are treatments that use laboratory-made antibodies designed to mimic the immune system’s ability to target and neutralize specific pathogens or abnormal cells. For instance, in September 2024, Amgen Inc., a US-based biotechnology company, announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved TEPEZZA (teprotumumab) for treating active thyroid eye disease (TED), a rare and potentially vision-threatening autoimmune disorder. It is the first and only FDA-approved therapy specifically for TED, offering a targeted treatment that helps reduce inflammation, swelling, and other debilitating symptoms associated with the disease. This approval is particularly important for patients in Japan, as it provides a new, effective option to manage TED, a rare and progressive condition that causes debilitating eye bulging, vision problems, and eye pain.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market? Amgen Acquires Horizon Therapeutics To Strengthen Rare And Inflammatory Disease Portfolio

In October 2023, Amgen Inc., a US-based biopharmaceutical company, acquired Horizon Therapeutics plc for an undisclosed amount. With this acquisition, Amgen aims to strengthen its rare and inflammatory disease portfolio by leveraging Horizon’s key therapies, expanding global reach, and accelerating innovation for long-term growth. Horizon Therapeutics plc is an Ireland-based company that specializes in rare autoimmune and inflammatory diseases.

What Is The Regional Outlook For The Global Thyroid Eye Disease (TED) Market?

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thyroid Eye Disease (TED) Market?

The thyroid eye disease (TED) market includes revenues earned by entities by providing services such as diagnosis services, pharmaceutical services, surgical services, support, and counseling services and related products including thyroid hormone replacement therapy, immunosuppressive drugs, surgical products, and devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Thyroid Eye Disease (TED) Industry?

The thyroid eye disease (ted) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid eye disease (ted) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Thyroid Eye Disease TED Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.29 billion
Revenue Forecast In 2034	$2.94 billion
Growth Rate	CAGR of 6.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The thyroid eye disease (TED) market covered in this report is segmented – 1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical 2) By Disease Severity: Mild, Moderate, Severe 3) By Drug Type: Biologics, Small Molecules, Others Drug Type 4) By Route Of Administration: Oral, Intravenous, Subcutaneous 5) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments 2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery 3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Thyroid Eye Disease (TED) Market Characteristics

3. Thyroid Eye Disease (TED) Market Trends And Strategies

4. Thyroid Eye Disease (TED) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Thyroid Eye Disease (TED) Growth Analysis And Strategic Analysis Framework

5.1. Global Thyroid Eye Disease (TED) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Thyroid Eye Disease (TED) Market Growth Rate Analysis

5.4. Global Thyroid Eye Disease (TED) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Thyroid Eye Disease (TED) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Thyroid Eye Disease (TED) Total Addressable Market (TAM)

6. Thyroid Eye Disease (TED) Market Segmentation

6.1. Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medical

Surgical

Combination Of Medical And Surgical

6.2. Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mild

Moderate

Severe

6.3. Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biologics

Small Molecules

Others Drug Type

6.4. Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Subcutaneous

6.5. Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End Users

6.6. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Corticosteroids

Teprotumumab

Antithyroid Medications

Other Medical Treatments

6.7. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Orbital Decompression Surgery

Eyelid Surgery

Strabismus Surgery

6.8. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination Of Corticosteroids And Orbital Decompression

Combination Of Teprotumumab And Eyelid Surgery

Other Combined Approaches

7. Thyroid Eye Disease (TED) Market Regional And Country Analysis

7.1. Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Thyroid Eye Disease (TED) Market

8.1. Asia-Pacific Thyroid Eye Disease (TED) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Thyroid Eye Disease (TED) Market

9.1. China Thyroid Eye Disease (TED) Market Overview

9.2. China Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Thyroid Eye Disease (TED) Market

10.1. India Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Thyroid Eye Disease (TED) Market

11.1. Japan Thyroid Eye Disease (TED) Market Overview

11.2. Japan Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Thyroid Eye Disease (TED) Market

12.1. Australia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Thyroid Eye Disease (TED) Market

13.1. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Thyroid Eye Disease (TED) Market

14.1. South Korea Thyroid Eye Disease (TED) Market Overview

14.2. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Thyroid Eye Disease (TED) Market

15.1. Western Europe Thyroid Eye Disease (TED) Market Overview

15.2. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Thyroid Eye Disease (TED) Market

16.1. UK Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Thyroid Eye Disease (TED) Market

17.1. Germany Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Thyroid Eye Disease (TED) Market

18.1. France Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Thyroid Eye Disease (TED) Market

19.1. Italy Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Thyroid Eye Disease (TED) Market

20.1. Spain Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Thyroid Eye Disease (TED) Market

21.1. Eastern Europe Thyroid Eye Disease (TED) Market Overview

21.2. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Thyroid Eye Disease (TED) Market

22.1. Russia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Thyroid Eye Disease (TED) Market

23.1. North America Thyroid Eye Disease (TED) Market Overview

23.2. North America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Thyroid Eye Disease (TED) Market

24.1. USA Thyroid Eye Disease (TED) Market Overview

24.2. USA Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Thyroid Eye Disease (TED) Market

25.1. Canada Thyroid Eye Disease (TED) Market Overview

25.2. Canada Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Thyroid Eye Disease (TED) Market

26.1. South America Thyroid Eye Disease (TED) Market Overview

26.2. South America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Thyroid Eye Disease (TED) Market

27.1. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Thyroid Eye Disease (TED) Market

28.1. Middle East Thyroid Eye Disease (TED) Market Overview

28.2. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Thyroid Eye Disease (TED) Market

29.1. Africa Thyroid Eye Disease (TED) Market Overview

29.2. Africa Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Thyroid Eye Disease (TED) Market Competitive Landscape And Company Profiles

30.1. Thyroid Eye Disease (TED) Market Competitive Landscape

30.2. Thyroid Eye Disease (TED) Market Company Profiles

30.2.1. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Horizon Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Pierre Fabre S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Thyroid Eye Disease (TED) Market Other Major And Innovative Companies

31.1. Innovent Biologics Inc.

31.2. ACELYRIN Inc.

31.3. Soleo Health

31.4. Zai Lab Limited

31.5. HanAll Biopharma Co. Ltd.

31.6. Tourmaline Bio Inc.

31.7. Zenas BioPharma Inc.

31.8. Immunovant Inc.

31.9. Verana Health

31.10. Harbour BioMed (Guangzhou) Co. Ltd.

31.11. Sling Therapeutics Inc.

31.12. Crinetics Pharmaceuticals Inc.

31.13. Lassen Therapeutics Inc.

31.14. Viridian Therapeutics Inc.

31.15. Minghui Pharmaceutical Inc.

32. Global Thyroid Eye Disease (TED) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market

34. Recent Developments In The Thyroid Eye Disease (TED) Market

35. Thyroid Eye Disease (TED) Market High Potential Countries, Segments and Strategies

35.1 Thyroid Eye Disease (TED) Market In 2029 - Countries Offering Most New Opportunities

35.2 Thyroid Eye Disease (TED) Market In 2029 - Segments Offering Most New Opportunities

35.3 Thyroid Eye Disease (TED) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Hoffmann-La Roche AG Financial Performance

Table 80: Amgen Inc. Financial Performance

Table 81: Genentech Inc. Financial Performance

Table 82: Horizon Therapeutics plc Financial Performance

Table 83: Pierre Fabre S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Hoffmann-La Roche AG Financial Performance

Figure 80: Amgen Inc. Financial Performance

Figure 81: Genentech Inc. Financial Performance

Figure 82: Horizon Therapeutics plc Financial Performance

Figure 83: Pierre Fabre S.A. Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Eye Melanoma Global Market Report 2025 – By Site (Uvea, Sclera, Retina), By Diagnosis (Imaging, Biopsy, Eye Exam), By Treatment (Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment), By End User ...

Thyroid Function Test Global Market Report 2025 – By Test Type (Thyroid Stimulating Hormone (TSH), Triiodothyronine (T,, Thyroxine (T,, Free triiodothyronine (FT,, Free Thyroxine (FT,), By Indication (Hypothyroidism, Hyp...

Thyroid Cancer Diagnostics Global Market Report 2025 – By Technique Type (Imaging Test, Blood Test, Biopsy, Other Test Type), By Disease Type (Papillary Carcinoma, Follicular Carcinoma, Other Diseases), By End-User (Hosp...

Optic Nerve Disorders Treatment Global Market Report 2025 – By Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), By Indication (Glaucoma, Optic Neuritis, Optic Neuropathy, Congenital Op...

Ophthalmic Eye Dropper Global Market Report 2025 – By Eye Dropper (Unidose Eye Dropper, Preserved Multi-Dose Eye Dropper, Preservative-Free Multi-Dose Eye Dropper), By Drug Type (Prescription Drugs, Over-The-Counter (OTC...

Anemia And Other Blood Disorder Drugs Global Market Report 2025 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Di...

Ophthalmic Drugs Global Market Report 2025 – By Type (Prescription Drugs, Over-The-Counter Drugs), By Class (Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes), By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye...

Frequently Asked Questions

What is the definition of the Thyroid Eye Disease (TED) market?

How will the Thyroid Eye Disease (TED) market drivers and restraints affect the market dynamics? What forces will shape the Thyroid Eye Disease (TED) industry going forward?

The market major growth driver - Thyroid Disorders And Their Influence On The Market Dynamics. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Thyroid Eye Disease (TED) market?

The thyroid eye disease (ted) market size has grown strongly in recent years. It will grow from $2.15 billion in 2024 to $2.29 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rising thyroid disorders, growing focus on patient-centered care, increasing demand for cosmetic procedures, increasing prevalence of the disease, and increasing treatment options for TED. The thyroid eye disease (ted) market size is expected to see strong growth in the next few years. It will grow to " $2.94 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the increasing prevalence of Graves' disease, increasing funding in various industries, increasing healthcare expenditure, increasing use of thyroid hormone replacement therapy, and rising incidence of thyroid disease. Major trends in the forecast period include technological advancements, expanding R&D activities, development of novel drugs, advancements in treatment options, and new surgical techniques. For further insights on this market, request a sample here

How is the Thyroid Eye Disease (TED) market segmented?

The thyroid eye disease (ted)market covered in this report is segmented –
1) By Treatment Type: Medical; Surgical; Combination Of Medical And Surgical
2) By Disease Severity: Mild; Moderate; Severe
3) By Drug Type: Biologics; Small Molecules; Others Drug Type
4) By Route Of Administration: Oral; Intravenous; Subcutaneous
5) By End User: Hospitals; Clinics; Other End Users Subsegments:
1) By Medical: Corticosteroids; Teprotumumab; Antithyroid Medications; Other Medical Treatments
2) By Surgical: Orbital Decompression Surgery; Eyelid Surgery; Strabismus Surgery
3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression; Combination of Teprotumumab and Eyelid Surgery; Other Combined Approaches For further insights on this market, request a sample here

Which region has the largest share of the Thyroid Eye Disease (TED) market? What are the other regions covered in the report?

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Thyroid Eye Disease (TED) market?

What are the key trends in the Thyroid Eye Disease (TED) market?

Major trends in this market include Amgen's TEPEZZA (Teprotumumab)A Breakthrough In Thyroid Eye Disease Treatment. For further insights on this market, request a sample here.